124 New COVID-19 Cases Since Friday at Noon

Zero New Deaths

There Have Been 30,464 Total Positive Cases

862 Deaths

MOHAVE COUNTY, AZ (November 1, 2021) — The Mohave County Health Department (MCDPH) Nursing staff has been notified of 124 new confirmed COVID-19 cases reported since Friday at noon. There are zero new deaths reported.

ALL 124 new confirmed cases remain under investigation.

Of the 124 new confirmed cases, there are 49 new confirmed cases in the Bullhead City service area There are 31 new confirmed cases in the Kingman service area. There are 35 new confirmed cases in the Lake Havasu City service area. There are 0 new confirmed cases in the North County service area. There are 0 new confirmed cases in an Undetermined or Unknown area of the county.

Of the 49 new confirmed cases in the Bullhead City area, one is 0-10; one is 11-19; fourteen are 20-29; seven are 30-39; none are 40-49; fifteen are 50-59; four are 60-69; five are 70-79; two are 80-89.

Of the 31 new confirmed cases in the Kingman area, three are 0-10; three are 11-19; four are 20-29; six are 30-39; six are 40-49; six are 50-59; and three are 60-69.

Of the 35 new confirmed cases in the Lake Havasu City area, two are 0-10; four are 11-19; five are 20-29; five are 30-39; none are 40-49; two are 50-59; eight are 60-69; five are 70-79; three are 80-89; one is 90+.

Of the 6 new confirmed cases in the North County area, one is 0-10; one is 20-29; one is 30-39; two are 60-69; one is 80-89.

Of the 3 new confirmed cases in an Unknown/Undetermined area of the county, one is 11-19; one is 60-69; one is 70-79.

TOTAL POSITIVE CASES SINCE 1^ST CASE REPORTED –—–30,464

TOTAL RECOVERED THUS FAR: 27,051

AVERAGE AGE OF CASES SINCE CASE #1: 45.3

AVERAGE AGE OF DEATHS SINCE FIRST DEATH: 73.9

Important Reminder: Even those fully vaccinated can still get COVID-19.  The vaccine reduces the severity of the virus and hospitalizations.  It does not mean individuals are totally immune from Covid-19.

__________________________________________________________

 Updated Current Vaccination Information

The U.S. Food and Drug Administration (FDA) has authorized, and the Centers for Disease Control and Prevention (CDC) has recommended booster doses of all three COVID-19 vaccines available in the United States.

Pfizer and Moderna Booster Dose

For individuals who received a Pfizer-BioNTech or Moderna COVID-19 vaccine, the following groups are eligible for a booster shot at 6 months or more after their initial series:

• 65 years and older
• Age 18+ who live in long-term care settings
• Age 18+ who have underlying medical conditions
• Age 18+ who work or live in high-risk settings

Johnson & Johnson (J&J)

For those persons who received the Johnson & Johnson COVID-19 vaccine, booster shots are also recommended for those who are 18 and older and who were vaccinated two or more months ago.

Booster Dosage:

• Pfizer = full dose
• Moderna = ½ dose
• J&J = full dose

Eligible individuals may choose which vaccine they receive as a booster dose. Some people may prefer the vaccine type that they originally received while others may prefer to get a different booster. CDC’s recommendations now allow for this type of mix and match dosing for booster shots.

For more information on booster doses and eligibility, please visit:

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html

https://www.cdc.gov/media/releases/2021/p1021-covid-booster.html

Treatment Options

Monoclonal Antibody Therapy (FDA Emergency Use Authorization)

While vaccines provide the best protection from COVID-19, treatment options such as Monoclonal Antibody therapy can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization.

Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus like the virus that causes COVID-19. That’s why mAb treatment may help patients who are at high risk for severe symptoms or hospitalization.

The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19. This treatment is not a substitute for vaccination against COVID-19.

General eligibility information is below.

• Individuals who have tested positive for COVID-19 and are within ten days of onset
• Unvaccinated individuals who have had close contact with a COVID positive person
• Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person

Each facility has its own standards for administering the Monoclonal Antibody Therapy. Please visit their respective websites or call the number provided below for more information.

Kingman Regional Medical Center (KRMC)

Website: https://www.azkrmc.com/seeking-medicalcare-covid-19

Phone Number: 928-681-8699

Western Arizona Regional Medical Center (WARMC)

Website: https://www.warmc.com/newsroom/antibody-therapy-now-offered-forcovid19-patients-16364

Phone number: 928-763- 2273

Havasu Urgent Care (aka Havasu Primary Care and Pediatrics)

Phone number: 928-505-1030

Veklury® (Remdesivir) (FDA approved)

Veklury® (Remdesivir) works by slowing the replication of the COVID-19 virus, thereby reducing the amount of virus circulating in the body.

Veklury® (Remdesivir) is approved for hospitalized patients age 12 years and older who weigh at least 88 pounds, with more severe COVID-19 disease. Your hospital care team will decide if you are eligible to receive this treatment.

Protect yourself and others

o   Get the COVID-19 vaccine (ages 12 and up).

o   Wash your hands often with soap and water for at least 20 seconds. If soap and water are not available, use an alcohol-based hand sanitizer.

o   Avoid touching your eyes, nose, and mouth with unwashed hands.

o   Stay home as much as possible, but especially when you are sick.

o   Put distance between yourself and other people, at least 6 feet.

o   Avoid gathering in groups of 10 or more.

o   Cover your cough or sneeze with a tissue, then throw the tissue in the trash.

o   Clean and disinfect frequently touched objects and surfaces.

o   Wear a face covering when in indoor public places.

If you have COVID-19 questions, please call 928-753-8665

This brought to you by